Oruka Therapeutics (ORKA) EBT Growth (3y) (2013 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.79% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 47.54% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -49.71% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 12.01% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 20.92% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.05% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67% |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 17.87% |
| Mar 31, 2024 | 21.16% |
| Dec 31, 2023 | 40.33% |
| Sep 30, 2023 | 10.57% |
| Jun 30, 2023 | -4.12% |
| Mar 31, 2023 | -0.65% |
| Dec 31, 2022 | 1.86% |
| Sep 30, 2022 | -24.88% |
| Jun 30, 2022 | -29.09% |
| Mar 31, 2022 | -23.29% |
| Dec 31, 2021 | -56.21% |
| Sep 30, 2021 | -42.63% |
| Jun 30, 2021 | -31.70% |
| Mar 31, 2021 | -14.45% |
| Dec 31, 2020 | -6.37% |
| Sep 30, 2020 | 23.42% |
| Jun 30, 2020 | 38.08% |
| Mar 31, 2020 | 32.74% |
| Dec 31, 2019 | 33.61% |
| Sep 30, 2019 | 36.41% |
| Jun 30, 2019 | 27.84% |
| Mar 31, 2019 | 21.77% |
| Dec 31, 2018 | 22.25% |
| Sep 30, 2018 | 16.74% |
| Jun 30, 2018 | 8.02% |
| Mar 31, 2018 | 0.11% |
| Dec 31, 2017 | -17.71% |
| Sep 30, 2017 | -24.74% |
| Jun 30, 2017 | -31.93% |
| Mar 31, 2017 | -22.00% |
| Dec 31, 2016 | -12.94% |
| Sep 30, 2016 | -39.32% |
| Jun 30, 2016 | -48.09% |
| Mar 31, 2016 | -50.45% |
| Dec 31, 2015 | -55.66% |
| Sep 30, 2015 | -44.79% |
| Jun 30, 2015 | -33.38% |
| Mar 31, 2015 | -24.94% |
| Dec 31, 2014 | -17.01% |
| Sep 30, 2014 | -7.82% |
| Jun 30, 2014 | -116.73% |
| Mar 31, 2014 | -2.69% |
| Dec 31, 2013 | -22.69% |
| Sep 30, 2013 | 6.47% |
| Jun 30, 2013 | 19.17% |